Codexis, Inc. (CDXS)
NASDAQ
Market Cap
$435.78M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
86 of 966
Rank in Industry
65 of 554
Largest Insider Buys in Sector
CDXS Stock Price History Chart
CDXS Stock Performance
About Codexis, Inc.
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Insider Activity of Codexis, Inc.
Over the last 12 months, insiders at Codexis, Inc. have bought $3.82M and sold $0 worth of Codexis, Inc. stock.
On average, over the past 5 years, insiders at Codexis, Inc. have bought $1.99M and sold $4.46M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Opaleye Management Inc. (10 percent owner) — $22.94M.
The last purchase of 25,000 shares for transaction amount of $72,720 was made by Opaleye Management Inc. (10 percent owner) on 2024‑10‑25.
List of Insider Buy and Sell Transactions, Codexis, Inc.
| 2024-10-25 | 10 percent owner | 25,000 0.0311% | $2.91 | $72,720 | 0.00% | |||
| 2024-09-25 | 10 percent owner | 5,000 0.0069% | $2.86 | $14,291 | +8.46% | |||
| 2024-09-24 | 10 percent owner | 80,000 0.1134% | $2.94 | $234,856 | +5.60% | |||
| 2024-09-23 | 10 percent owner | 45,000 0.064% | $2.94 | $132,485 | +19.86% | |||
| 2024-09-20 | 10 percent owner | 1.05M 1.4443% | $3.01 | $3.18M | +12.74% | |||
| 2024-09-18 | 10 percent owner | 61,000 0.0875% | $3.16 | $192,992 | +10.93% | |||
| 2023-11-15 | Sale | director | 20,000 0.0289% | $2.11 | $42,168 | +47.86% | ||
| 2023-09-11 | Chief Operating Officer | 9,000 0.0126% | $1.72 | $15,479 | +64.20% | |||
| 2023-09-08 | See Remarks | 58,479 0.0841% | $1.73 | $100,952 | +68.31% | |||
| 2023-09-08 | Chief Financial Officer | 11,650 0.0165% | $1.70 | $19,856 | +68.31% | |||
| 2023-09-08 | See Remarks | 11,834 0.0167% | $1.70 | $20,065 | +68.31% | |||
| 2023-04-18 | Sale | director | 35,714 0.0539% | $4.14 | $147,874 | -34.74% | ||
| 2023-04-17 | Sale | director | 35,714 0.0529% | $4.24 | $151,377 | -37.44% | ||
| 2023-03-16 | Sale | director | 35,714 0.054% | $4.11 | $146,681 | -34.04% | ||
| 2023-03-15 | Sale | director | 35,714 0.0533% | $4.09 | $146,131 | -34.62% | ||
| 2023-03-08 | Sale | See Remarks | 26,987 0.0411% | $4.56 | $122,931 | -40.09% | ||
| 2023-03-08 | Sale | Chief Operating Officer | 8,258 0.0126% | $4.56 | $37,617 | -40.09% | ||
| 2023-03-08 | Sale | See remarks | 7,686 0.0117% | $4.56 | $35,011 | -40.09% | ||
| 2023-03-07 | Sale | See Remarks | 28,088 0.0426% | $4.60 | $129,281 | -40.87% | ||
| 2023-03-07 | Sale | Chief Operating Officer | 8,596 0.013% | $4.60 | $39,565 | -40.87% |
Insider Historical Profitability
9.71%
| Opaleye Management Inc. | 10 percent owner | 8545000 10.5004% | $5.36 | 6 | 0 | |
| NICOLS JOHN J | director | 783965 0.9634% | $5.36 | 4 | 31 | <0.0001% |
| DILLY STEPHEN GEORGE | See Remarks | 438878 0.5393% | $5.36 | 1 | 2 | |
| KELLEY BERNARD J | director | 206136 0.2533% | $5.36 | 0 | 16 | |
| SHAW ALAN | President and CEO | 202000 0.2482% | $5.36 | 1 | 12 | +25.75% |
| Dorgan Byron L | director | 193461 0.2377% | $5.36 | 0 | 9 | |
| SANGSTER GORDON | SVP & Chief Financial Officer | 134453 0.1652% | $5.36 | 0 | 8 | |
| Lalonde James | SVP, R&D | 133402 0.1639% | $5.36 | 0 | 14 | |
| Ryali Sriram | Chief Financial Officer | 123441 0.1517% | $5.36 | 1 | 0 | |
| O'Toole David D | SVP & Chief Financial Officer | 115384 0.1418% | $5.36 | 4 | 0 | <0.0001% |
| VIVO VENTURES VII, LLC | 10 percent owner | 112940 0.1388% | $5.36 | 0 | 5 | |
| Norrett Kevin | Chief Operating Officer | 98102 0.1206% | $5.36 | 1 | 2 | |
| Vivo Ventures Fund VII, L.P. | 10 percent owner | 90330 0.111% | $5.36 | 0 | 1 | |
| Fitzgerald Margaret Nell | See Remarks | 81420 0.1001% | $5.36 | 1 | 2 | |
| Anton David L. | SVP, BioIndustrials | 70200 0.0863% | $5.36 | 1 | 1 | +25.75% |
| Sheehy Douglas T. | SVP, General Counsel & Sec. | 69200 0.085% | $5.36 | 1 | 1 | +25.75% |
| Glaub Kathleen Sereda | director | 63534 0.0781% | $5.36 | 0 | 3 | |
| Cheng Pam P. | director | 58719 0.0722% | $5.36 | 0 | 2 | |
| Smith David V | director | 56679 0.0696% | $5.36 | 0 | 1 | |
| Lawson Robert J | SVP and CFO | 44000 0.0541% | $5.36 | 2 | 0 | <0.0001% |
| Yang Patrick Y | 42512 0.0522% | $5.36 | 12 | 12 | +15.01% | |
| BARUCH THOMAS R | director | 33093 0.0407% | $5.36 | 1 | 15 | +28.81% |
| WOLF DENNIS P | 30925 0.038% | $5.36 | 0 | 22 | ||
| Pasternack Bruce A | director | 10000 0.0123% | $5.36 | 3 | 0 | +29.98% |
| Sarret Joseph J. | CBO, President Pharmaceuticals | 2000 0.0025% | $5.36 | 1 | 0 | +25.75% |
| CMEA VENTURES LIFE SCIENCES 2000 LP | 0 0% | $5.36 | 0 | 1 | ||
| Aldridge Michael D. | See Remarks | 0 0% | $5.36 | 0 | 2 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| BlackRock | $23.09M | 9.38 | 6.61M | -8.08% | -$2.03M | <0.01 | |
| Nantahala Capital Management Llc | $15.57M | 6.32 | 4.46M | -2.85% | -$457,277.24 | 0.73 | |
| Fidelity Investments | $15.47M | 6.28 | 4.43M | +1.54% | +$234,447.73 | <0.01 | |
| The Vanguard Group | $14.86M | 6.04 | 4.26M | +3.14% | +$452,907.76 | <0.0001 | |
| Baillie Gifford Co | $12.02M | 4.88 | 3.45M | +0.77% | +$91,493.84 | 0.01 | |
| Opaleye Management Inc | $10.89M | 4.42 | 3.12M | +2.44% | +$259,917.75 | 2.4 | |
| Telemark Asset Management LLC | $9.41M | 3.82 | 2.7M | 0% | +$0 | 1.03 | |
| Casdin Capital | $6.98M | 2.84 | 2M | 0% | +$0 | 0.35 | |
| Nuveen | $5.74M | 2.33 | 1.64M | -19.56% | -$1.39M | <0.01 | |
| Geode Capital Management | $5.45M | 2.22 | 1.56M | +3.19% | +$168,541.08 | <0.0001 | |
| State Street | $5.27M | 2.14 | 1.51M | +1.75% | +$90,931.96 | <0.0001 | |
| Assenagon Asset Management S.A. | $5.08M | 2.07 | 1.46M | 0% | +$0 | 0.01 | |
| Federated Hermes | $4.72M | 1.92 | 1.35M | +0.85% | +$39,960.50 | 0.01 | |
| Ameriprise Financial | $4.53M | 1.84 | 1.3M | +5.43% | +$233,481.01 | <0.01 | |
| Jacobs Levy Equity Management | $3.65M | 1.48 | 1.05M | -23.49% | -$1.12M | 0.01 | |
| Paradigm Capital Management Inc Ny | $3.14M | 1.28 | 900,000 | 0% | +$0 | 0.15 | |
| Two Sigma Advisers LP | $3.03M | 1.23 | 867,700 | -7.18% | -$234,179.00 | 0.01 | |
| Acadian Asset Management | $2.72M | 1.11 | 779,335 | -0.36% | -$9,807.10 | 0.01 | |
| Kent Lake Capital LLC | $2.2M | 0.89 | 629,399 | New | +$2.2M | 0.99 | |
| Northern Trust | $2.06M | 0.84 | 591,677 | -3.52% | -$75,380.52 | <0.0001 | |
| Two Sigma | $1.86M | 0.75 | 531,778 | -8.94% | -$182,216.37 | <0.01 | |
| Alger | $1.77M | 0.72 | 508,095 | +17.35% | +$262,120.01 | 0.01 | |
| Prescott Group Capital Management LLC | $1.58M | 0.64 | 453,125 | -14.59% | -$269,969.38 | 0.19 | |
| Vivo Capital | $1.35M | 0.55 | 388,144 | 0% | +$0 | 0.12 | |
| Renaissance Technologies | $1.27M | 0.52 | 363,986 | New | +$1.27M | <0.01 | |
| Citadel Advisors LLC | $1.23M | 0.5 | 351,546 | +175.52% | +$781,596.26 | <0.01 | |
| Millennium Management LLC | $1.16M | 0.47 | 332,866 | -46.22% | -$998,450.32 | <0.01 | |
| Dimensional Fund Advisors | $884,035.00 | 0.36 | 253,305 | +20.15% | +$148,283.21 | <0.0001 | |
| BNY Mellon | $879,577.00 | 0.36 | 252,028 | -4.73% | -$43,663.35 | <0.0001 | |
| Bridgeway Capital Management | $844,580.00 | 0.34 | 242,000 | +22.84% | +$157,050.00 | 0.01 | |
| Private Advisor Group | $807,379.00 | 0.33 | 231,341 | +22.09% | +$146,073.75 | 0.01 | |
| PLATINUM INVESTMENT MANAGEMENT LTD | $801,538.00 | 0.33 | 229,667 | New | +$801,538.00 | 0.01 | |
| Morgan Stanley | $780,762.00 | 0.32 | 223,714 | -38.74% | -$493,828.11 | <0.0001 | |
| Goldman Sachs | $720,057.00 | 0.29 | 206,320 | -19.07% | -$169,715.26 | <0.0001 | |
| Charles Schwab | $713,893.00 | 0.29 | 204,554 | -3.39% | -$25,058.18 | <0.0001 | |
| Eam Investors | $696,164.00 | 0.28 | 199,474 | New | +$696,164.00 | 0.04 | |
| Royal Bank of Canada | $688,000.00 | 0.28 | 197,261 | +24.7% | +$136,287.90 | <0.0001 | |
| D. E. Shaw & Co. | $591,827.00 | 0.24 | 169,578 | -81.39% | -$2.59M | <0.01 | |
| Barclays | $575,000.00 | 0.23 | 164,576 | -23.61% | -$177,664.57 | <0.0001 | |
| Envestnet Asset Management Inc | $564,155.00 | 0.23 | 161,649 | +34.98% | +$146,185.63 | <0.0001 | |
| Standard Life | $560,428.00 | 0.23 | 160,581 | 0% | +$0 | <0.01 | |
| Perkins Capital Management Inc | $557,000.00 | 0.23 | 159,600 | +242.49% | +$394,367.17 | 0.48 | |
| Cubist Systematic Strategies | $552,097.00 | 0.22 | 158,194 | +140.34% | +$322,385.22 | 0.01 | |
| Engineers Gate Manager Lp | $540,838.00 | 0.22 | 154,968 | -26.65% | -$196,483.39 | 0.01 | |
| WHITE PINE CAPITAL, LLC | $442,739.00 | 0.22 | 152,144 | +2.63% | +$11,360.64 | 0.17 | |
| Ohio Strs | $507,000.00 | 0.21 | 145,300 | -42.45% | -$374,056.43 | <0.01 | |
| Stifel | $483,417.00 | 0.2 | 138,515 | New | +$483,417.00 | <0.01 | |
| AQR Capital | $453,934.00 | 0.18 | 130,067 | -31.17% | -$205,568.06 | <0.01 | |
| LINSCO PRIVATE LEDGER CORP | $409,778.00 | 0.17 | 117,415 | +34.09% | +$104,172.92 | <0.0001 | |
| RhumbLine Advisers | $364,960.00 | 0.15 | 104,577 | +2.8% | +$9,925.19 | <0.0001 |
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.